Literature DB >> 7261280

Obesity and cardiac function.

O de Divitiis, S Fazio, M Petitto, G Maddalena, F Contaldo, M Mancini.   

Abstract

We studied 10 obese volunteers, mean age 36.5 +/- 10.3 years, who weighed 123.56 +/- 28.7 g and were 69.96 +/- 22.5 kg overweight. The subjects did not have diabetes, arterial hypertension or signs of cardiac and respiratory failure or disease and all underwent right- and left-heart catheterization. cardiac output and stroke volume were high, according to increased oxygen consumption and to the degree of obesity. Ventricular end-diastolic and atrial pressures ranged from normal to high and correlated with body weight, signs of volume overloading and reduced left ventricular (LV) compliance. The mean pulmonary artery pressure was elevated and correlated well with weight, pulmonary resistance being normal; mean aortic pressure did not correlate with weight, and systemic arterial resistance tended to have a negative correlation. The LV function curve showed impaired ventricular function, particularly for the heaviest subjects, in whom Vmax and the ratio of the stroke work index to LV end-diastolic pressure were reduced. These indexes correlated well with each other and both correlated negatively with the degree of obesity. In contrast, maximal dP/dt was normal and did not correlate with excess weight. These observations show that depressed LV function is already present in relatively young obese people, even if they are free from signs of cardiopathy and other associate diseases. The degree of impairment of heart function seems to parallel the degree of obesity.

Entities:  

Mesh:

Year:  1981        PMID: 7261280     DOI: 10.1161/01.cir.64.3.477

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  66 in total

Review 1.  Effects of obesity on pharmacokinetics implications for drug therapy.

Authors:  G Cheymol
Journal:  Clin Pharmacokinet       Date:  2000-09       Impact factor: 6.447

2.  Obesity decreases perioperative tissue oxygenation.

Authors:  Barbara Kabon; Angelika Nagele; Dayakar Reddy; Chris Eagon; James W Fleshman; Daniel I Sessler; Andrea Kurz
Journal:  Anesthesiology       Date:  2004-02       Impact factor: 7.892

Review 3.  Cardiovascular risks in obesity.

Authors:  E C Uchegbu; P G Kopelman
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

4.  Supplemental postoperative oxygen and tissue oxygen tension in morbidly obese patients.

Authors:  Barbara Kabon; Romana Rozum; Corinna Marschalek; Gerhard Prager; Edith Fleischmann; Astrid Chiari; Andrea Kurz
Journal:  Obes Surg       Date:  2010-07       Impact factor: 4.129

Review 5.  Heart failure and obesity in adults: pathophysiology, clinical manifestations and management.

Authors:  Martin A Alpert; Harsh Agrawal; Kul Aggarwal; Senthil A Kumar; Arun Kumar
Journal:  Curr Heart Fail Rep       Date:  2014-06

6.  Targeted ablation at stable atrial fibrillation sources improves success over conventional ablation in high-risk patients: a substudy of the CONFIRM Trial.

Authors:  Tina Baykaner; Paul Clopton; Gautam G Lalani; Amir A Schricker; David E Krummen; Sanjiv M Narayan
Journal:  Can J Cardiol       Date:  2013-08-30       Impact factor: 5.223

Review 7.  [Anesthesia and bariatric surgery].

Authors:  F M Konrad; K M Kramer; T H Schroeder; K Stubbig
Journal:  Anaesthesist       Date:  2011-07       Impact factor: 1.041

8.  Effects of isolated obesity on systolic and diastolic left ventricular function.

Authors:  M Pascual; D A Pascual; F Soria; T Vicente; A M Hernández; F J Tébar; M Valdés
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

9.  Diet-induced obesity alters vincristine pharmacokinetics in blood and tissues of mice.

Authors:  James W Behan; Vassilios I Avramis; Jason P Yun; Stan G Louie; Steven D Mittelman
Journal:  Pharmacol Res       Date:  2010-01-18       Impact factor: 7.658

10.  Abnormal Central Pulsatile Hemodynamics in Adolescents With Obesity: Higher Aortic Forward Pressure Wave Amplitude Is Independently Associated With Greater Left Ventricular Mass.

Authors:  Gary L Pierce; Mohanasundari Pajaniappan; Amy DiPietro; Kathryn Darracott-Woei-A-Sack; Gaston K Kapuku
Journal:  Hypertension       Date:  2016-09-12       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.